We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
American Vanguard (AVD) Q2 Earnings & Sales Beat Estimates
Read MoreHide Full Article
American Vanguard’s (AVD - Free Report) profits for second-quarter 2017 was $4.3 million or 15 cents per share, up around 33% from $3.2 million or 11 cents a year ago. Earnings per share beat the Zacks Consensus Estimate by a penny. The results were supported by the company’s cost control initiatives.
Revenues rose 7% year over year to $77.9 million in the reported quarter, coming ahead of the Zacks Consensus Estimate of $77 million. Sales were partly driven by strong demand for cotton products.
Moreover, the company saw healthy gains in international sales and growth in its granular soil insecticide products in the reported quarter on the back of higher demand in domestic corn, peanuts and sugar crops. This more than offset weather-related declines in soil fumigant sales and pricing pressure in corn herbicides.
The company’s sales from the U.S. went up 8% to $55.8 million, while international revenues rose 6% to $22.1 million.
American Vanguard Corporation Price, Consensus and EPS Surprise
Revenues from American Vanguard’s insecticides business climbed 28% to $39.4 million in the reported quarter.
Sales from the herbicides/soil fumigants/fungicides business fell around 24% year over year to $16 million in the quarter.
Revenues from the other business went up around 59% year over year to $10.1 million.
Financials
American Vanguard ended the quarter with cash and cash equivalents of $7.6 million, up around 31% year over year. Long-term debt was to $26.3 million, down 47% year over year.
Outlook
Moving ahead, American Vanguard said that its outlook for the remainder of 2017 is positive. The company noted that significant increase cotton acreage in the U.S. should provide additional sales of its Bidrin foliar insecticide and Folex harvest defoliant in the second half of 2017. American Vanguard also sees modest international growth and a rebound in its soil fumigant business. Moreover, the company expects continued demand for its Dibrom mosquito adulticide. The company remains focused on managing working capital and operational costs and investing in technology innovation for future growth.
Price Performance
American Vanguard’s shares gained 15.3% over the past year, outperforming the 4.1% gain of the industry it belongs to.
Zacks Rank & Key Picks
American Vanguard currently carries a Zacks Rank #2 (Buy).
Westlake has an expected long-term earnings growth of 7.2%.
Air Products has an expected long-term earnings growth of 11.9%.
Chemours has an expected long-term earnings growth of 15.5%.
Today's Stocks from Zacks' Hottest Strategies It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively. And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation. See Them Free>>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
American Vanguard (AVD) Q2 Earnings & Sales Beat Estimates
American Vanguard’s (AVD - Free Report) profits for second-quarter 2017 was $4.3 million or 15 cents per share, up around 33% from $3.2 million or 11 cents a year ago. Earnings per share beat the Zacks Consensus Estimate by a penny. The results were supported by the company’s cost control initiatives.
Revenues rose 7% year over year to $77.9 million in the reported quarter, coming ahead of the Zacks Consensus Estimate of $77 million. Sales were partly driven by strong demand for cotton products.
Moreover, the company saw healthy gains in international sales and growth in its granular soil insecticide products in the reported quarter on the back of higher demand in domestic corn, peanuts and sugar crops. This more than offset weather-related declines in soil fumigant sales and pricing pressure in corn herbicides.
The company’s sales from the U.S. went up 8% to $55.8 million, while international revenues rose 6% to $22.1 million.
American Vanguard Corporation Price, Consensus and EPS Surprise
American Vanguard Corporation Price, Consensus and EPS Surprise | American Vanguard Corporation Quote
Segment Highlights
Revenues from American Vanguard’s insecticides business climbed 28% to $39.4 million in the reported quarter.
Sales from the herbicides/soil fumigants/fungicides business fell around 24% year over year to $16 million in the quarter.
Revenues from the other business went up around 59% year over year to $10.1 million.
Financials
American Vanguard ended the quarter with cash and cash equivalents of $7.6 million, up around 31% year over year. Long-term debt was to $26.3 million, down 47% year over year.
Outlook
Moving ahead, American Vanguard said that its outlook for the remainder of 2017 is positive. The company noted that significant increase cotton acreage in the U.S. should provide additional sales of its Bidrin foliar insecticide and Folex harvest defoliant in the second half of 2017. American Vanguard also sees modest international growth and a rebound in its soil fumigant business. Moreover, the company expects continued demand for its Dibrom mosquito adulticide. The company remains focused on managing working capital and operational costs and investing in technology innovation for future growth.
Price Performance
American Vanguard’s shares gained 15.3% over the past year, outperforming the 4.1% gain of the industry it belongs to.
Zacks Rank & Key Picks
American Vanguard currently carries a Zacks Rank #2 (Buy).
Other well-placed companies in the basic materials space include Westlake Chemical Corporation (WLK - Free Report) , Air Products and Chemicals, Inc. (APD - Free Report) and The Chemours Company (CC - Free Report) , all sporting a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Westlake has an expected long-term earnings growth of 7.2%.
Air Products has an expected long-term earnings growth of 11.9%.
Chemours has an expected long-term earnings growth of 15.5%.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively. And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation. See Them Free>>